Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001673232-26-000006

PRESIDENT AND COO sold 14,625 shares at an average $464.66 ($6,795,627)

  • PRESIDENT AND COO acquired 14,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

BENKOWITZ MICHAEL · PRESIDENT AND COO

Table I: Non-derivative

15 lines
Date Transaction Shares Price Value Owned after D/I
2026-01-20 Exercise or conversion : show line 1 in the form 10b5-1 −14,625 $117.76 $1,722,240 14,625 I
2026-01-20 Sale : show line 2 in the form 10b5-1 −116 $456.87 $52,996 14,509 I
2026-01-20 Sale : show line 3 in the form 10b5-1 −692 $457.92 $316,879 13,817 I
2026-01-20 Sale : show line 4 in the form 10b5-1 −700 $458.74 $321,116 13,117 I
2026-01-20 Sale : show line 5 in the form 10b5-1 −498 $459.87 $229,013 12,619 I
2026-01-20 Sale : show line 6 in the form 10b5-1 −503 $461.12 $231,943 12,116 I
2026-01-20 Sale : show line 7 in the form 10b5-1 −2,456 $463.26 $1,137,768 9,660 I
2026-01-20 Sale : show line 8 in the form 10b5-1 −2,274 $464.06 $1,055,264 7,386 I
Open-market sales · 14,625 sh · avg $464.66 · $6,795,627

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-01-20 Exercise or conversion : show line 16 in the form 10b5-1 Common Stock −14,625 67,875 I
Loading xslF345X05/primarydocument.xml…